Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections owing to characteristics such as their high specificity and their ability to …

Cell-free gene expression (CFE) emerged as an alternative approach to living cells for
specific applications in protein synthesis and labelling for structural biology and proteomics …

The antibody response to influenza is primarily focused on the head region of the
hemagglutinin (HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating …

Influenza virus infections are a major public health concern and cause significant morbidity
and mortality worldwide. Current influenza virus vaccines are an effective countermeasure …

Crude extract based cell-free protein synthesis (CFPS) has emerged as a powerful
technology platform for high-throughput protein production and genetic part characterization …

Adjuvanted soluble protein vaccines have been used extensively in humans for protection
against various viral infections based on their robust induction of antibody responses. Here …

Although antiviral drugs and vaccines have reduced the economic and healthcare burdens
of influenza, influenza epidemics continue to take a toll. Over the past decade, research on …

Synthetic biology aims to design or assemble existing bioparts or bio-components for useful
bioproperties. During the past decades, progresses have been made to build delicate …

The identification of human broadly neutralizing antibodies (bnAbs) targeting the
hemagglutinin (HA) stem revitalized hopes of developing a universal influenza vaccine …

Cell-free protein synthesis (CFPS) system is a simple, rapid, and sensitive tool that is devoid
of membrane-bound barriers, yet contains all the mandatory substrates, biomolecules, and …